I Levine et al. Inflamm Bowel Dis 2021; 809-815. Prevalence, Predictors, and Disease Activity of Sacroiliitis Among Patients with Crohn’s Disease
Key findings in this cross-sectional retrospective study (n=258, median age 30 yrs):
- Overall, 17% of patients had MRI evidence of sacroiliitis, of whom 73% demonstrated bone marrow edema.
- Female gender, back pain, and later age of CD diagnosis were associated with sacroiliitis (P = 0.05, P < 0.001, P = 0.04, respectively).
- Disease activity (clinical, endoscopic, and radiographic), disease location and CD therapy were not associated with sacroiliitis on MRE.
- More than two-thirds with MRE evidence of sacroiliitis were never seen by a rheumatologist.
A Lin et al. Inflamm Bowel Dis 2021; 947-955. Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Key finding:
- Data pooled from 27 studies showed the prevalence of NAFLD among IBD patients was 32% (substantial heterogeneity); this is “statistically significantly higher than the prevalence of NAFLD in the general population (25.2%; P < 0.001)”
M Attauabi et al. Inflamm Bowel Dis 2021; 927-939. Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases
A total of 93 studies were identified, comprising 16,064 IBD patients with co-occurring IMIDs and 3,451,414 IBD patients without IMIDs. IMIDs included the following:
- Unspecified autoimmune disease
- Diabetes type 1
- Asthma
- Grave disease
- Spondyloarthropathy
- Ankylosing spondylitis
- Iridocyclitis
- Uveitis
- Rheumatoid arthritis
- Polymyalgia rheumatica
- Psoriasis/psoriatic arthritis
- Primary Sclerosing Cholangitis
- Celiac disease
- Pyoderma gangrenosum
- Pernicious anemia
- Autoimmune hepatitis
- Sarcoidosis
- Giant cell arteritis
- Primary biliary cholangitis
- Hashimoto thyroiditis
- Episcleritis
- Sjogren syndrome
Key findings: Patients with IBD and co-occurring IMIDs were at increased risk of having extensive colitis or pancolitis (risk ratio, 1.38; 95% Cl, 1.25–1.52; P < 0.01, I2 = 86%) and receiving IBD-related surgeries (risk ratio, 1.17; 95% Cl, 1.01–1.36; P = 0.03; I2 = 85%) compared with patients without IMIDs
Image below from Bahia Honda State Park (FL)
